USD 16.41
(0.0%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 | 346.03 Billion JPY | 13.41% |
2023 | 326.33 Billion JPY | 7.97% |
2022 | 302.25 Billion JPY | 8.2% |
2021 | 279.36 Billion JPY | 10.83% |
2020 | 252.06 Billion JPY | 13.32% |
2019 | 222.43 Billion JPY | 12.93% |
2018 | 196.95 Billion JPY | 14.41% |
2017 | 172.15 Billion JPY | 23.05% |
2016 | 139.9 Billion JPY | 23.52% |
2015 | 113.25 Billion JPY | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 FY | 346.03 Billion JPY | 6.04% |
2024 Q1 | 86.89 Billion JPY | -6.64% |
2024 Q4 | 94.51 Billion JPY | 7.35% |
2024 Q3 | 88.04 Billion JPY | -9.29% |
2024 Q2 | 97.06 Billion JPY | 11.71% |
2023 Q2 | 92.19 Billion JPY | 18.43% |
2023 Q1 | 77.84 Billion JPY | -10.24% |
2023 FY | 326.33 Billion JPY | 7.97% |
2023 Q4 | 93.07 Billion JPY | 11.19% |
2023 Q3 | 83.7 Billion JPY | -9.21% |
2022 Q2 | 82.73 Billion JPY | 11.56% |
2022 Q1 | 74.16 Billion JPY | -4.18% |
2022 FY | 302.25 Billion JPY | 8.2% |
2022 Q4 | 86.72 Billion JPY | 15.1% |
2022 Q3 | 75.34 Billion JPY | -8.93% |
2021 Q1 | 69.52 Billion JPY | -5.32% |
2021 Q2 | 78.17 Billion JPY | 12.44% |
2021 Q4 | 77.39 Billion JPY | 9.08% |
2021 FY | 279.36 Billion JPY | 10.83% |
2021 Q3 | 70.95 Billion JPY | -9.23% |
2020 FY | 252.06 Billion JPY | 13.32% |
2020 Q2 | 66.66 Billion JPY | 4.8% |
2020 Q4 | 73.43 Billion JPY | 15.19% |
2020 Q1 | 63.61 Billion JPY | 0.08% |
2020 Q3 | 63.75 Billion JPY | -4.37% |
2019 Q4 | 63.55 Billion JPY | 11.22% |
2019 FY | 222.43 Billion JPY | 12.93% |
2019 Q3 | 57.14 Billion JPY | -4.93% |
2019 Q2 | 60.1 Billion JPY | 7.63% |
2019 Q1 | 55.84 Billion JPY | -1.19% |
2018 Q2 | 52.62 Billion JPY | 7.01% |
2018 FY | 196.95 Billion JPY | 14.41% |
2018 Q4 | 56.52 Billion JPY | 9.49% |
2018 Q1 | 49.17 Billion JPY | 0.14% |
2018 Q3 | 51.62 Billion JPY | -1.91% |
2017 Q2 | 46.49 Billion JPY | 7.88% |
2017 FY | 172.15 Billion JPY | 23.05% |
2017 Q4 | 49.1 Billion JPY | 8.87% |
2017 Q3 | 45.1 Billion JPY | -2.99% |
2017 Q1 | 43.1 Billion JPY | -2.58% |
2016 Q1 | 31.06 Billion JPY | 0.0% |
2016 FY | 139.9 Billion JPY | 23.52% |
2016 Q4 | 44.24 Billion JPY | 6.64% |
2016 Q3 | 41.48 Billion JPY | 25.26% |
2016 Q2 | 33.12 Billion JPY | 6.63% |
2015 FY | 113.25 Billion JPY | 0.0% |
2015 Q2 | 28.64 Billion JPY | 5.27% |
2015 Q3 | 27.81 Billion JPY | -2.92% |
2015 Q1 | 27.21 Billion JPY | 3.95% |
2014 Q4 | 26.18 Billion JPY | 3.16% |
2014 Q3 | 25.37 Billion JPY | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Alternative Energy Partners, Inc. | - USD | -Infinity% |
Allstar Health Brands, Inc. | - USD | -Infinity% |
Beijing Tong Ren Tang Chinese Medicine Company Limited | 134.07 Million USD | -257983.097% |
Café Serendipity Holdings, Inc. | 1196.00 USD | -28932608595.652% |
Decision Diagnostics Corp. | - USD | -Infinity% |
Health Advance Inc. | - USD | -Infinity% |
HealthWarehouse.com, Inc. | 12.17 Million USD | -2842321.219% |
LIGAND PHARMACEUTICAL INC | 88.02 Million USD | -393004.31% |
MedGen, Inc. | 1.05 USD | -32955619047519.048% |
Omni Health, Inc. | 1.55 Million USD | -22288107.154% |
Oxford Investments Holdings Inc. | 31.45 Thousand USD | -1099987184.633% |
Pineapple, Inc. | -1.02 Million USD | 33769661.976% |
ScripsAmerica, Inc. | 27.59 Million USD | -1253778.625% |